These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22324550)

  • 1. Neuropeptide Y-induced phase shifts of PER2::LUC rhythms are mediated by long-term suppression of neuronal excitability in a phase-specific manner.
    Besing RC; Hablitz LM; Paul JR; Johnson RL; Prosser RA; Gamble KL
    Chronobiol Int; 2012 Mar; 29(2):91-102. PubMed ID: 22324550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suprachiasmatic nucleus function and circadian entrainment are modulated by G protein-coupled inwardly rectifying (GIRK) channels.
    Hablitz LM; Molzof HE; Paul JR; Johnson RL; Gamble KL
    J Physiol; 2014 Nov; 592(22):5079-92. PubMed ID: 25217379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IA Channels Encoded by Kv1.4 and Kv4.2 Regulate Circadian Period of PER2 Expression in the Suprachiasmatic Nucleus.
    Granados-Fuentes D; Hermanstyne TO; Carrasquillo Y; Nerbonne JM; Herzog ED
    J Biol Rhythms; 2015 Oct; 30(5):396-407. PubMed ID: 26152125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium Circadian Rhythmicity in the Suprachiasmatic Nucleus: Cell Autonomy and Network Modulation.
    Noguchi T; Leise TL; Kingsbury NJ; Diemer T; Wang LL; Henson MA; Welsh DK
    eNeuro; 2017; 4(4):. PubMed ID: 28828400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes.
    Gribkoff VK; Pieschl RL; Wisialowski TA; van den Pol AN; Yocca FD
    J Neurosci; 1998 Apr; 18(8):3014-22. PubMed ID: 9526018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid phase shifts the rhythmic expression of Period2::Luciferase.
    Johansson AS; Brask J; Owe-Larsson B; Hetta J; Lundkvist GB
    J Biol Rhythms; 2011 Dec; 26(6):541-51. PubMed ID: 22215612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of circadian light induced phase advances and delays by neuropeptide Y and a neuropeptide Y Y1/Y5 receptor agonist.
    Lall GS; Biello SM
    Neuroscience; 2003; 119(2):611-8. PubMed ID: 12770573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y differentially suppresses per1 and per2 mRNA induced by light in the suprachiasmatic nuclei of the golden hamster.
    Brewer JM; Yannielli PC; Harrington ME
    J Biol Rhythms; 2002 Feb; 17(1):28-39. PubMed ID: 11837945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness.
    Huhman KL; Albers HE
    Peptides; 1994; 15(8):1475-8. PubMed ID: 7700850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y rapidly reduces Period 1 and Period 2 mRNA levels in the hamster suprachiasmatic nucleus.
    Fukuhara C; Brewer JM; Dirden JC; Bittman EL; Tosini G; Harrington ME
    Neurosci Lett; 2001 Nov; 314(3):119-22. PubMed ID: 11704298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrin-releasing peptide mediates light-like resetting of the suprachiasmatic nucleus circadian pacemaker through cAMP response element-binding protein and Per1 activation.
    Gamble KL; Allen GC; Zhou T; McMahon DG
    J Neurosci; 2007 Oct; 27(44):12078-87. PubMed ID: 17978049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y blocks GABAB-induced phase-shifts of the suprachiasmatic circadian clock in vitro.
    Biggs KR; Prosser RA
    Brain Res; 1999 Mar; 821(2):461-6. PubMed ID: 10064833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tau mutation of casein kinase 1ε sets the period of the mammalian pacemaker via regulation of Period1 or Period2 clock proteins.
    Maywood ES; Chesham JE; Smyllie NJ; Hastings MH
    J Biol Rhythms; 2014 Apr; 29(2):110-8. PubMed ID: 24682205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian control during the day and night: Role of neuropeptide Y Y5 receptors in the suprachiasmatic nucleus.
    Gamble KL; Ehlen JC; Albers HE
    Brain Res Bull; 2005 May; 65(6):513-9. PubMed ID: 15862923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.
    Yannielli PC; Harrington ME
    J Neurosci; 2001 Jul; 21(14):5367-73. PubMed ID: 11438613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian phase shifts to neuropeptide Y In vitro: cellular communication and signal transduction.
    Biello SM; Golombek DA; Schak KM; Harrington ME
    J Neurosci; 1997 Nov; 17(21):8468-75. PubMed ID: 9334419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y blocks serotonergic phase shifts of the suprachiasmatic circadian clock in vitro.
    Prosser RA
    Brain Res; 1998 Oct; 808(1):31-41. PubMed ID: 9795117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing actions of neuropeptide Y and light on the expression of circadian clock genes in the mouse suprachiasmatic nuclei.
    Maywood ES; Okamura H; Hastings MH
    Eur J Neurosci; 2002 Jan; 15(1):216-20. PubMed ID: 11860521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immortalized cell lines for real-time analysis of circadian pacemaker and peripheral oscillator properties.
    Farnell YF; Shende VR; Neuendorff N; Allen GC; Earnest DJ
    Eur J Neurosci; 2011 Apr; 33(8):1533-40. PubMed ID: 21366728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term constant light potentiation of large-magnitude circadian phase shifts induced by 8-OH-DPAT: effects on serotonin receptors and gene expression in the hamster suprachiasmatic nucleus.
    Duncan MJ; Franklin KM; Davis VA; Grossman GH; Knoch ME; Glass JD
    Eur J Neurosci; 2005 Nov; 22(9):2306-14. PubMed ID: 16262668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.